BIOCYTOGEN PHARMACEUTICALS (BEIJING revenue breakdown overview

BIOCYTOGEN PHARMACEUTICALS (BEIJING revenue for the last year amounted to 1.04 B HKD, the most of which — 421.99 M HKD — came from its highest performing source at the moment, Animal Models Selling, the year earlier bringing 301.45 M HKD. The greatest contribution to the revenue figure was made by United States — last year it brought BIOCYTOGEN PHARMACEUTICALS (BEIJING 536.02 M HKD, and the year before that — 332.79 M HKD.